These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Images in clinical medicine. Frey's syndrome. Prattico F; Perfetti P N Engl J Med; 2006 Jul; 355(1):66. PubMed ID: 16822997 [No Abstract] [Full Text] [Related]
3. The use of botulinum toxin in Frey's Syndrome. Khoo SG; Keogh IJ; Timon C Ir Med J; 2006 May; 99(5):136-7. PubMed ID: 16892916 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Frey's syndrome with type A botulinum toxin: case report. von Lindern JJ; Niederhagen B; Bergé S; Reich RH J Oral Maxillofac Surg; 2000 Dec; 58(12):1411-4. PubMed ID: 11117691 [No Abstract] [Full Text] [Related]
6. Botulinum toxoid in the management of gustatory sweating (Frey's syndrome) after superficial parotidectomy. Birch JF; Varma SK; Narula AA Br J Plast Surg; 1999 Apr; 52(3):230-1. PubMed ID: 10474477 [TBL] [Abstract][Full Text] [Related]
7. Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations. Guntinas-Lichius O; Gabriel B; Klussmann JP Acta Otolaryngol; 2006 Oct; 126(10):1104-9. PubMed ID: 16923718 [TBL] [Abstract][Full Text] [Related]
8. A comparison of incidence of Frey's syndrome diagnosed based on clinical signs and Minor's test after parotis surgery. Tuncel A; Karaman M; Sheidaei S; Tatlıpınar A; Esen E Kulak Burun Bogaz Ihtis Derg; 2012; 22(4):200-6. PubMed ID: 22770254 [TBL] [Abstract][Full Text] [Related]
9. Application of medical thermography to the diagnosis of Frey's syndrome. Isogai N; Kamiishi H Head Neck; 1997 Mar; 19(2):143-7. PubMed ID: 9059873 [TBL] [Abstract][Full Text] [Related]
10. [Gustatory sweating syndrome or Frey's syndrome: a revision]. De Amesti C; Orús C; Jurgens A; Fuentes CG; Burgués J An Otorrinolaringol Ibero Am; 1994; 21(1):65-76. PubMed ID: 8166380 [No Abstract] [Full Text] [Related]
11. [Developments in and results of surgical treatment of pleomorphic adenoma of the parotid gland in 245 patients, 1974-1994]. Oomen JL Ned Tijdschr Geneeskd; 1996 Dec; 140(50):2529. PubMed ID: 9005340 [No Abstract] [Full Text] [Related]
12. Superficial parotidectomy: technical modifications based on tumour characteristics. Papadogeorgakis N; Skouteris CA; Mylonas AI; Angelopoulos AP J Craniomaxillofac Surg; 2004 Dec; 32(6):350-3. PubMed ID: 15555516 [TBL] [Abstract][Full Text] [Related]
13. Frey's syndrome after parotidectomy: a retrospective and prospective analysis. Linder TE; Huber A; Schmid S Laryngoscope; 1997 Nov; 107(11 Pt 1):1496-501. PubMed ID: 9369396 [TBL] [Abstract][Full Text] [Related]
14. Use of allogenic acellular dermal matrix in prevention of Frey's syndrome after parotidectomy. Ye WM; Zhu HG; Zheng JW; Wang XD; Zhao W; Zhong LP; Zhang ZY Br J Oral Maxillofac Surg; 2008 Dec; 46(8):649-52. PubMed ID: 18547692 [TBL] [Abstract][Full Text] [Related]
15. Role of limited parotidectomy in management of pleomorphic adenoma. Johnson JT; Ferlito A; Fagan JJ; Bradley PJ; Rinaldo A J Laryngol Otol; 2007 Dec; 121(12):1126-8. PubMed ID: 17666140 [TBL] [Abstract][Full Text] [Related]